Search | Page 33 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes: What do hospitalists need to know?

    ... is a misconception that anemia (a low red blood cell count) is normal in the elderly and that a workup is not warranted in ... decitabine (Dacogen®), intensive chemotherapy, and stem cell transplantation.  Patients tend to tolerate azacitidine and ...

    Research Review last updated 05/02/2016 - 9:21am.

  2. Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

    ... Purpose:  Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy for patients ... mortality (NRM), but recent advances utilizing post-transplant cyclophosphamide (PT-Cy) have revolutionized haplo-HCT and ... Stem cell transplant Drug: Azacitidine Other Names: Vidaza Ladakamycin ...

    Clinical Trial last updated 05/03/2016 - 11:15am.

  3. Incidence and Burden of the Myelodysplastic Syndromes

    ... costs and require more hospital services.  -Red-blood cell transfusion dependence is associated with increased mortality and worse ... be considered for a clinical trial or allogeneic stem cell transplant if available.  This is a large unmet need in MDS.  ...

    Research Review last updated 05/02/2016 - 9:11am.

  4. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). This study aims to determine if any of three new ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  5. Nurse's Corner Summer 2015: Understanding the Etiology and Epidemiology of Myelodysplastic Syndromes

    ... Syndromes (MDS) are a group of malignant hematopoietic stem cell diseases characterized by bone marrow failure , with resultant ...

    Page last updated 07/27/2015 - 12:04pm.

  6. A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

    ... for potentially curative options such as allogeneic stem cell transplant . No chemotherapy or study drugs for >3 weeks prior to ...

    Clinical Trial last updated 06/03/2016 - 3:09pm.

  7. Graft-vs-host-disease (GVHD): Signs, Symptoms, and Treatment

    ... An allogeneic stem cell transplant uses blood-forming cells ( stem cells ) donated by ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  8. Clinical Trials Report for June 2015

    ... engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens ...

    Page last updated 06/18/2015 - 11:47am.

  9. Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

    ... infusion of their donor's bone marrow or blood stem cells . The high-dose chemotherapy drugs and radiation are given to ... Not breastfeeding INCLUSION CRITERIA - HPC-A CELL DONOR At least 18 years of age. Family member (first degree ...

    Clinical Trial last updated 05/09/2016 - 3:01pm.

  10. TBI Dose De-escalation for Fanconi Anemia

    ... thymic shielding; it will be given six days before the stem cells are given (day -6). 2) Day -5 through Day -2, subjects will ... stem cells (cells collected from the donor's arm via a cell separator), on the day of transplantation, the stem cells taken from the ...

    Clinical Trial last updated 04/28/2016 - 9:06am.